1
|
Chai K, Yang J, Tu Y, Wu J, Fang K, Shi S, Yao T. Molecular Deformation Is a Key Factor in Screening Aggregation Inhibitor for Intrinsically Disordered Protein Tau. ACS CENTRAL SCIENCE 2024; 10:717-728. [PMID: 38559297 PMCID: PMC10979476 DOI: 10.1021/acscentsci.3c01196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/26/2023] [Revised: 02/03/2024] [Accepted: 02/16/2024] [Indexed: 04/04/2024]
Abstract
Direct inhibitor of tau aggregation has been extensively studied as potential therapeutic agents for Alzheimer's disease. However, the natively unfolded structure of tau complicates the structure-based ligand design, and the relatively large surface areas that mediate tau-tau interactions in aggregation limit the potential for identifying high-affinity ligand binding sites. Herein, a group of isatin-pyrrolidinylpyridine derivative isomers (IPP1-IPP4) were designed and synthesized. They are like different forms of molecular "transformers". These isatin isomers exhibit different inhibitory effects on tau self-aggregation or even possess a depolymerizing effect. Our results revealed for the first time that the direct inhibitor of tau protein aggregation is not only determined by the previously reported conjugated structure, substituent, hydrogen bond donor, etc. but also depends more importantly on the molecular shape. In combination with molecular docking and molecular dynamics simulations, a new inhibition mechanism was proposed: like a "molecular clip", IPP1 could noncovalently bind and fix a tau polypeptide chain at a multipoint to prevent the transition from the "natively unfolded conformation" to the "aggregation competent conformation" before nucleation. At the cellular and animal levels, the effectiveness of the inhibitor of the IPP1 has been confirmed, providing an innovative design strategy as well as a lead compound for Alzheimer's disease drug development.
Collapse
Affiliation(s)
- Keke Chai
- School
of Chemical Science and Engineering, Shanghai Key Laboratory of Chemical
Assessment and Sustainability, Tongji University, Shanghai 200092, China
| | - Jian Yang
- School
of Medicine, Shanghai University, Shanghai 200444, China
| | - Ying Tu
- School
of Chemical Science and Engineering, Shanghai Key Laboratory of Chemical
Assessment and Sustainability, Tongji University, Shanghai 200092, China
| | - Junjie Wu
- School
of Chemical Science and Engineering, Shanghai Key Laboratory of Chemical
Assessment and Sustainability, Tongji University, Shanghai 200092, China
| | - Kang Fang
- School
of Chemical Science and Engineering, Shanghai Key Laboratory of Chemical
Assessment and Sustainability, Tongji University, Shanghai 200092, China
| | - Shuo Shi
- School
of Chemical Science and Engineering, Shanghai Key Laboratory of Chemical
Assessment and Sustainability, Tongji University, Shanghai 200092, China
| | - Tianming Yao
- School
of Chemical Science and Engineering, Shanghai Key Laboratory of Chemical
Assessment and Sustainability, Tongji University, Shanghai 200092, China
| |
Collapse
|
2
|
Torán R, Miguélez R, Sanz‐Marco A, Vila C, Pedro JR, Blay G. Asymmetric Addition and Cycloaddition Reactions with Ylidene‐Five‐Membered Heterocycles. Adv Synth Catal 2021. [DOI: 10.1002/adsc.202100979] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Affiliation(s)
- Ricardo Torán
- Departament de Química Orgànica Universitat de València C/Dr. Moliner 50 46100- Burjassot (València) Spain
| | - Rubén Miguélez
- Departament de Química Orgànica Universitat de València C/Dr. Moliner 50 46100- Burjassot (València) Spain
| | - Amparo Sanz‐Marco
- Departament de Química Orgànica Universitat de València C/Dr. Moliner 50 46100- Burjassot (València) Spain
| | - Carlos Vila
- Departament de Química Orgànica Universitat de València C/Dr. Moliner 50 46100- Burjassot (València) Spain
| | - José R. Pedro
- Departament de Química Orgànica Universitat de València C/Dr. Moliner 50 46100- Burjassot (València) Spain
| | - Gonzalo Blay
- Departament de Química Orgànica Universitat de València C/Dr. Moliner 50 46100- Burjassot (València) Spain
| |
Collapse
|
3
|
Ziu I, Rettig I, Luo D, Dutta A, McCormick TM, Wu C, Martic S. The multifunctional dopamine D 2/D 3 receptor agonists also possess inhibitory activity against the full-length tau441 protein aggregation. Bioorg Med Chem 2020; 28:115667. [PMID: 32828429 PMCID: PMC10879933 DOI: 10.1016/j.bmc.2020.115667] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2020] [Revised: 07/07/2020] [Accepted: 07/24/2020] [Indexed: 10/23/2022]
Abstract
Neurodegeneration leads to variety of diseases which are linked to aberrant protein or peptide aggregation, as a one possible mechanism. Hence, small drug molecules targeting aggregation are of interest. Tau protein aggregation is one of the biomarkers of neurodegenerative diseases and is a viable drug target. Toward multifunctional inhibitors, we aim to incorporate structural elements in a potential drug in order to preserve dopamine agonist activity, which elevates disease symptoms associated with motor skills, and promote inhibitory activity against aggregation of the full-length tau (2N4R, tau441) protein. In our design, we introduced various moieties (catechol, non-catechol, biphenyl, piperazine, and thiazole) to determine which functional group leads to the greatest aggregation inhibition of tau. In vitro, tau aggregation was induced by heparin and monitored by using fluorescence aggregation assay, transmission electron microscopy and 4,4'-Dianilino-1,1'-binaphthyl-5,5'-disulfonic acid dipotassium salt (Bis-ANS) fluorescence spectroscopy. The catechol containing compounds, D-519 and D-520, prevented aggregation of tau. By contrast, non-catechol and thiazole containing compounds (D-264 and D-636) were poor inhibitors. The Bis-ANS studies revealed that the potent inhibitors bound solvent-exposed hydrophobic sites. Based on the density functional theory calculations on inhibitors tested, the compounds characterized with the high polarity and polarizability were more effective aggregation inhibitors. These findings could lead to the development of small multifunctional drug inhibitors for the treatment of tau-associated neurodegeneration.
Collapse
Affiliation(s)
- Iva Ziu
- Department of Chemistry, Oakland University, Rochester, MI 48309, USA
| | - Irving Rettig
- Department of Chemistry, Portland State University, Portland, OR 97201, USA
| | - Dan Luo
- Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA
| | - Aloke Dutta
- Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA
| | | | - Colin Wu
- Department of Chemistry, Oakland University, Rochester, MI 48309, USA
| | - Sanela Martic
- Department of Forensic Science, Environmental and Life Sciences, Trent University, Peterborough, ON K9J 0G2, Canada.
| |
Collapse
|
4
|
Horishny VY, Chaban TI, Matiychuk VS. Synthesis of 5-(Het)arylidene-3-[2-(4-hydroxyphenyl)ethyl]-2-thioxothiazolidine-4-one Derivatives and Study of Their Antitumor and Anti-Inflammatory Activity. RUSS J GEN CHEM+ 2020. [DOI: 10.1134/s1070363220070063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
5
|
Mousavi SM, Zarei M, Hashemi SA, Babapoor A, Amani AM. A conceptual review of rhodanine: current applications of antiviral drugs, anticancer and antimicrobial activities. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY 2019; 47:1132-1148. [DOI: 10.1080/21691401.2019.1573824] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Affiliation(s)
- Seyyed Mojtaba Mousavi
- Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Maryam Zarei
- Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Seyyed Alireza Hashemi
- Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Aziz Babapoor
- Department of Chemical Engineering, University of Mohaghegh Ardabili, Ardabil, Iran
| | - Ali Mohammad Amani
- Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| |
Collapse
|
6
|
Yavari I, Naeimabadi M, Halvagar MR. A diastereoselective synthesis of functionalized bis-spirorhodanine-linked cyclopentanes via C(sp 3 )–H activation. Tetrahedron 2018. [DOI: 10.1016/j.tet.2018.06.029] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
7
|
Tayeb-Fligelman E, Landau M. X-Ray Structural Study of Amyloid-Like Fibrils of Tau Peptides Bound to Small-Molecule Ligands. Methods Mol Biol 2017; 1523:89-100. [PMID: 27975245 DOI: 10.1007/978-1-4939-6598-4_5] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Atomic structures of Tau involved in Alzheimer's disease complexed with small molecule binders are the first step to define the Tau pharmacophore, leading the way to a structure-based design of improved diagnostics and therapeutics. Yet the partially disordered and polymorphic nature of Tau hinders structural analyses. Fortunately, short segments from amyloid proteins, which exhibit similar biophysical properties to the full-length proteins, also form fibrils and oligomers, and their atomic structures can be determined using X-ray microcrystallography. Such structures were successfully used to design amyloid inhibitors. This chapter describes experimental procedures used to determine crystal structures of Tau peptide segments in complex with small-molecule binders.
Collapse
Affiliation(s)
- Einav Tayeb-Fligelman
- Department of Biology, Technion-Israel Institute of Technology, Haifa, 3200003, Israel
| | - Meytal Landau
- Department of Biology, Technion-Israel Institute of Technology, Haifa, 3200003, Israel.
| |
Collapse
|
8
|
Generalizing the Concept of Specific Compound Formulation Additives towards Non-Fluorescent Drugs: A Solubilization Study on Potential Anti-Alzheimer-Active Small-Molecule Compounds. Angew Chem Int Ed Engl 2016; 55:8752-6. [DOI: 10.1002/anie.201601147] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2016] [Indexed: 11/07/2022]
|
9
|
Lawatscheck C, Pickhardt M, Wieczorek S, Grafmüller A, Mandelkow E, Börner HG. Erweiterung des Konzeptes spezifischer Wirkstoff-Formulierungsadditive auf nichtfluoreszierende Wirkstoffe: eine Studie zur Solubilisierung potenzieller Anti-Alzheimer-Wirkstoffe. Angew Chem Int Ed Engl 2016. [DOI: 10.1002/ange.201601147] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Carmen Lawatscheck
- Humboldt-Universität zu Berlin; Institut für Chemie; Brook-Taylor-Straße 2 12489 Berlin Deutschland
| | - Marcus Pickhardt
- Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE); Forschungszentrum CAESAR; Ludwig-Erhard-Allee 2 53175 Bonn Deutschland
| | - Sebastian Wieczorek
- Humboldt-Universität zu Berlin; Institut für Chemie; Brook-Taylor-Straße 2 12489 Berlin Deutschland
| | - Andrea Grafmüller
- Max-Planck-Institut für Kolloide und Grenzflächen; Abteilung Theorie & Bio-Systeme; Am Mühlenberg 1 14476 Potsdam Deutschland
| | - Eckhard Mandelkow
- Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE); Forschungszentrum CAESAR; Ludwig-Erhard-Allee 2 53175 Bonn Deutschland
- Max-Planck-Institut für Stoffwechselforschung; Außenstation Hamburg, c/o DESY; Hamburg Deutschland
| | - Hans G. Börner
- Humboldt-Universität zu Berlin; Institut für Chemie; Brook-Taylor-Straße 2 12489 Berlin Deutschland
| |
Collapse
|
10
|
Joshi P, Chia S, Habchi J, Knowles TPJ, Dobson CM, Vendruscolo M. A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins. ACS COMBINATORIAL SCIENCE 2016; 18:144-53. [PMID: 26923286 DOI: 10.1021/acscombsci.5b00129] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
The aggregation process of intrinsically disordered proteins (IDPs) has been associated with a wide range of neurodegenerative disorders, including Alzheimer's and Parkinson's diseases. Currently, however, no drug in clinical use targets IDP aggregation. To facilitate drug discovery programs in this important and challenging area, we describe a fragment-based approach of generating small-molecule libraries that target specific IDPs. The method is based on the use of molecular fragments extracted from compounds reported in the literature to inhibit of the aggregation of IDPs. These fragments are used to screen existing large generic libraries of small molecules to form smaller libraries specific for given IDPs. We illustrate this approach by describing three distinct small-molecule libraries to target, Aβ, tau, and α-synuclein, which are three IDPs implicated in Alzheimer's and Parkinson's diseases. The strategy described here offers novel opportunities for the identification of effective molecular scaffolds for drug discovery for neurodegenerative disorders and to provide insights into the mechanism of small-molecule binding to IDPs.
Collapse
Affiliation(s)
- Priyanka Joshi
- Department of Chemistry, University of Cambridge , Cambridge CB2 1EW, United Kingdom
| | - Sean Chia
- Department of Chemistry, University of Cambridge , Cambridge CB2 1EW, United Kingdom
| | - Johnny Habchi
- Department of Chemistry, University of Cambridge , Cambridge CB2 1EW, United Kingdom
| | - Tuomas P J Knowles
- Department of Chemistry, University of Cambridge , Cambridge CB2 1EW, United Kingdom
| | - Christopher M Dobson
- Department of Chemistry, University of Cambridge , Cambridge CB2 1EW, United Kingdom
| | - Michele Vendruscolo
- Department of Chemistry, University of Cambridge , Cambridge CB2 1EW, United Kingdom
| |
Collapse
|
11
|
Lim S, Haque MM, Kim D, Kim DJ, Kim YK. Cell-based Models To Investigate Tau Aggregation. Comput Struct Biotechnol J 2014; 12:7-13. [PMID: 25505502 PMCID: PMC4262059 DOI: 10.1016/j.csbj.2014.09.011] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2014] [Revised: 09/20/2014] [Accepted: 09/24/2014] [Indexed: 12/14/2022] Open
Abstract
Accumulation of abnormal tau aggregates in neuron is an important pathological signature in multiple neurodegenerative disorders including Alzheimer's disease. Tau is a neuron specific microtubule-associated protein that regulates microtubule stability, which is critical for axonal outgrowth and synaptic plasticity. In a pathological condition, tau dissociates from microtubules and forms insoluble aggregates called neurofibrillary tangles (NFTs). The accumulation of NFTs in neuron directly correlates with microtubule dysfunction and neuronal degeneration. Due to the pathophysiological importance of tau, great efforts have been made to understand tau aggregation processes and find therapeutics to halt or reverse the processes. However, progress has been slow due to the lack of a suitable method for monitoring tau aggregation. In this mini-review, we will review the conventional methods for studying tau aggregation, and introduce recent cell-based sensor approaches that allow monitoring tau aggregation in living cells.
Collapse
Affiliation(s)
- Sungsu Lim
- Center for Neuro-medicine, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul 136-791, Republic of Korea
| | - Md Mamunul Haque
- Center for Neuro-medicine, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul 136-791, Republic of Korea ; Biological Chemistry, University of Science and Technology, Daejon 305-333, Republic of Korea
| | - Dohee Kim
- Center for Neuro-medicine, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul 136-791, Republic of Korea ; Department of Biotechnology, Translational Research Center for Protein Function Control, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, Republic of Korea
| | - Dong Jin Kim
- Center for Neuro-medicine, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul 136-791, Republic of Korea
| | - Yun Kyung Kim
- Center for Neuro-medicine, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul 136-791, Republic of Korea
| |
Collapse
|
12
|
Mishra R, Sellin D, Radovan D, Gohlke A, Winter R. Inhibiting islet amyloid polypeptide fibril formation by the red wine compound resveratrol. Chembiochem 2009; 10:445-9. [PMID: 19165839 DOI: 10.1002/cbic.200800762] [Citation(s) in RCA: 113] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
GRAPES FOR AMYLOIDS: The red wine compound resveratrol can effectively inhibit the formation of IAPP amyloid that is found in type II diabetes. Our in vitro inhibition results do not depend on the antioxidant activity of resveratrol. Further, the markedly enhanced cell survival in the presence of resveratrol also indicates that the small oligomeric structures that are observed during beta-sheet formation are not toxic and could be off-pathway assembly products.
Collapse
Affiliation(s)
- Rajesh Mishra
- Faculty of Chemistry, Physical Chemistry I, Biophysical Chemistry, TU Dortmund, Dortmund, Germany
| | | | | | | | | |
Collapse
|
13
|
Bulic B, Pickhardt M, Schmidt B, Mandelkow EM, Waldmann H, Mandelkow E. Development of tau aggregation inhibitors for Alzheimer's disease. Angew Chem Int Ed Engl 2009; 48:1740-52. [PMID: 19189357 DOI: 10.1002/anie.200802621] [Citation(s) in RCA: 193] [Impact Index Per Article: 12.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
A variety of human diseases are suspected to be directly linked to protein misfolding. Highly organized protein aggregates, called amyloid fibrils, and aggregation intermediates are observed; these are considered to be mediators of cellular toxicity and thus attract a great deal of attention from investigators. Neurodegenerative pathologies such as Alzheimer's disease account for a major part of these protein misfolding diseases. The last decade has witnessed a renaissance of interest in inhibitors of tau aggregation as potential disease-modifying drugs for Alzheimer's disease and other "tauopathies". The recent report of a phase II clinical trial with the tau aggregation inhibitor MTC could hold promise for the validation of the concept. This Review summarizes the available data concerning small-molecule inhibitors of tau aggregation from a medicinal chemistry point of view.
Collapse
Affiliation(s)
- Bruno Bulic
- Max-Planck-Institute for Molecular Physiology, Dortmund, Germany.
| | | | | | | | | | | |
Collapse
|
14
|
Bulic B, Pickhardt M, Schmidt B, Mandelkow EM, Waldmann H, Mandelkow E. Entwicklung von Inhibitoren der Tau-Aggregation bei Morbus Alzheimer. Angew Chem Int Ed Engl 2009. [DOI: 10.1002/ange.200802621] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
15
|
Mishra R, Bulic B, Sellin D, Jha S, Waldmann H, Winter R. Small-molecule inhibitors of islet amyloid polypeptide fibril formation. Angew Chem Int Ed Engl 2008; 47:4679-82. [PMID: 18470855 DOI: 10.1002/anie.200705372] [Citation(s) in RCA: 95] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Rajesh Mishra
- Faculty of Chemistry, Physical Chemistry I-Biophysical Chemistry, Technical University Dortmund, Otto-Hahn-Strasse 6, 44227 Dortmund, Germany
| | | | | | | | | | | |
Collapse
|
16
|
Mishra R, Bulic B, Sellin D, Jha S, Waldmann H, Winter R. Small-Molecule Inhibitors of Islet Amyloid Polypeptide Fibril Formation. Angew Chem Int Ed Engl 2008. [DOI: 10.1002/ange.200705372] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|